MedTrace Logo

Inflammatory Markers in Patients With Active Migraine Headaches

NCT00471861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2011-08-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, such as Calcitonin Gene Peptide (CGRP), Vasoactive Intestinal Polypeptide (VIP) or Substance P (SP) are elevated in patients having a migraine headache.

Conditions

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Westside Family Medical Center, P.C.

    lead OTHER

Principal Investigators

  • Gary E Ruoff, MD · Westside Family Medical Center, P.C.

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471861 on ClinicalTrials.gov